Font Size




Menu Style

Options X Conference


  • Discounted isirv conference rates
  • Opportunities to network and connect with world experts in the field of respiratory virus diseases
Member Login


OPTIONS X - Singapore
28 August - 1 September 2019

Welcome to the 10th edition of the Options for the Control of Influenza conference in Singapore. This is ISIRV's premier event and remains the largest international conference exclusively dedicated to influenza prevention, control and treatment, including seasonal flu and pandemic preparedness. Highlights of the meeting include: new tracks on influenza co-infections with other viral pathogens and key issues for policy making - special sessions to showcase the latest developments in Chinese-speaking countries - pre-conference workshops on a wide variety of topics including  technology, mathematical modelling and bioinformatics. Registration will open shortly. Visit the website.   Outline Programme 


 Abstract Submission is now OPEN   

2nd Epidemiology Group Conference
16 - 18 January 2019

Incidence, Severity and Impact of Influenza - Stockholm

The next Epidemiology Group conference is planned to take place at the new ECDC facilities in Stockholm. This is an interdisciplinary meeting bringing together epidemiologists, clinical researchers, as well as experts in public health, risk analysis, big data and global health. The focus will be on severe disease presentations with influenza and other respiratory viral infections. Details are available on the website. Registration has closed. FINAL DETAILS

1st Influenza Vaccine Group Meeting
31 March - 2 April 2019
Immunological Assays and Correlates of Protection for Next Generation Influenza Vaccines - Siena, Italy

This conference will address new immunological assays and immune correlates of protection needed to estimate the immunogenicity and protective efficacy of next generation influenza vaccines currently being developed. Visit the website -  Abstract Submission has been extended to 31 January - Register here


FDA approve Xofluza, the anti-flu drug approved in Japan earlier in the year.   

Influenza Vaccine

The recommended composition of influenza virus vaccines for use in the 2016-2017 northern hemisphere influenza season can be found here.

Zoonotic Influenza

The update 'Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness' is here.


Information and links to other sources of information on this evolving situation is available in the news section.

New Group is announced - International Respiratory Syncytial Virus Society

In mid-2017, the International Respiratory Syncytial Virus Society (IRSVS) became a special interest group of isirv. The IRSVS is a global independent group of RSV professionals, with members from all continents working on all research fronts. The IRSVS’s goal is to ensure that there is a succession of venues to share scientific information and accelerate the development of strategies to reduce the impact of RSV infection. Read more...

Highlights from Influenza 2018: Centenary of the 1918 Pandemic | 24-26 June at the Crick Institute, London

The greatest public health disaster in recorded history, the Spanish Flu, began in springtime of 1918 and developed within a few months into a global pandemic with an estimated 50-100 million deaths. By its end, the pandemic had caused a reduction of life expectancy in the US by 12 years, and killed more people than died in the First World War. Read more...

11th International RSV Symposium, Asheville, NC, USA
The Final Programme & Abstract Book will be available shortly - further post-conference updates will be posted on this website